Life-science opportunities are assessed through ownership, mechanism, evidence, safety, development stage, manufacturing feasibility, regulatory route and commercial relevance. IIL does not present research hypotheses as established clinical outcomes.
Selected themes
- Lipid-based delivery systems for active substances.
- Artificial blood and blood-substitute research.
- Biomaterials and tissue-related platforms.
- Investigational biosignal and oncology concepts.